Phillip Frost, M.D.

Phillip Frost, M.D.

Chief Executive OfficeratOpko Health· In proxies 2021–2025

Pay in FY2025-14% from the year before · Opko Health stock -14.3% the same year

Phillip Frost, M.D. was paid $1.9M in FY2025 (Dec), down 14%. Opko Health stock fell 14.3% that year.

Pay$100 in the stock at the end of FY20 → $32
Pay is from the Summary Compensation Table of each Opko Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Opko HealthPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -62%
  2. Cocrystal Pharma, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Morgan SolarPublic company
    • Director? – PresentNo stock prices for these years
  4. Non-Invasive Monitoring Systems, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Key Pharmaceuticals, Inc.Public company · 54 yr
    • Director1972 – Present · 54 yrNo stock prices for these years
  6. Castle BrandsPublic company
    • Director? – PresentNo stock prices for these years
  7. Ladenburg Thalmann Financial Services Inc.Public company · 2 yr
    • Director2004 – 2006 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?